The α1 integrin subunit (SU) belongs to a large family of α and β subunits that are noncovalently linked to constitute αβ transmembrane units.
The α1 integrin subunit (SU) belongs to a large family of α and β subunits that are noncovalently linked to constitute αβ transmembrane units. To date, 18 α and 8 β subunits are known to form 24 αβ units (Takada et al., 2007; Barczyk et al., 2010) which are involved in cell-cell and cell-matrix attachment and can drive inside-out and outside-in cell signaling (Shattil et al., 2010) . Integrins are known to participate in different cell processes including cell shape, differentiation, migration, survival and proliferation (Giancotti, 1997; Vachon, 2011; Beauséjour et al., 2012) . The α1 SU was discovered in 1986 as the Very Late Antigen 1 (VLA1) and is highly expressed in activated lymphocytes in the joints of patients with rheumatoid arthritis (Hemler et al., 1986) . In fibroblasts, α1 is known to activate the RAS/ERK proliferative pathway and has a pro-invasive function in certain cancers. In megakaryocyte differentiation α1 is silenced by DNA methylation but not histone modification (Cheli et al., 2007) . Different transcription factors involved in cancer progression can bind to the ITGA1 promoter. Integrin α1 transcriptional regulation remains to be further defined.
Identity
Other names: CD49a, VLA1 HGNC (Hugo): ITGA1 Location: 5q11.2 
DNA/RNA

Description
The ITGA1 gene is 165354 bp in length and contains 29 exons that encode a protein of 1179 aa.
Transcription
Transcriptional regulation of the α1 integrin SU: transcriptional regulation of ITGA1 was first described in smooth muscle cells of the chicken in the proximal promoter of ITGA1 containing the CArG box for the serum response factor (SRF) (Obata et al., 1997) . Cheli et al. also reported that ITGA1 expression is predominantly regulated by DNA methylation and not histone modification in human HEK293 cells (Cheli et al., 2007 
Expression
Expression and localisation: the α1 integrin SU (figure 2) is highly expressed in various areas of the stroma. As reported previously, α1 is present in fibroblasts, endothelial cells and smooth muscle cells (Gardner, 2014) . In the gut, α1 is expressed in myofibroblast cells surrounding the crypts of the colon and small intestinal mucosa (Boudjadi et al., 2013) . α1 is present in epithelial cells of the endometrium, kidney and intestine. In the latter, α1 is present only in proliferating crypt cells while its exclusive partner β1 is constitutively expressed in all intestinal cells (Beaulieu, 1992; Boudjadi et al., 2013) . In these cells, α1 is observed in the basolateral portion of the cytoplasmic membrane (figure 3). Scale bars = 50 μm.
Function
α1β1 is the main cell receptor for collagen IV and with a lower affinity for collagen I, whereas α2β1 has a higher affinity for collagen I (Barczyk et al., 2010) . α1β1 recognizes the GEFOGER sequence within the tertiary structure of collagen IV.
It is important for cell anchorage to the extracellular matrix and is implicated in focal adhesions and cell migration. The presence of α1β1 in proliferating cells is supported by the reported role for α1, via caveolin-1 and Shc, in the downstream activation of the Ras/MEK/ERK proliferative pathway (Giancotti, 2000) . In endothelial cells, using a selective mutagenesis approach, specific amino acids in the α1 cytoplasmic tail are shown to drive various functions and pathways. While Lys 1147 is important only for tubulogenesis, Pro 1142 and Leu 1145 are required for ERK activation and cell proliferation. Lys 1146 is involved in cell adhesion, migration (activation of p38 MAPK) and tubulogenesis (activation of p38 MAPK and PI3K). Interestingly, substitution of the Lys 1151 positively charged amino acid at the COOHterminus of the α1 tail results in a complete loss of the above functions. This positively charged amino acid could be required for α1 orientation relative to the β1 tail, compromising binding to signal molecules (Abair et al., 2008) .
Mutations
Note No mutation known for human ITGA1 gene.
Implicated in
Lung cancer
Note In mouse models, the α1β1 integrin mediates cell invasion through the regulation of stromelysin-1 expression (Lochter et al., 1999) and, together with the Kras oncogenic factor, potentiates tumour growth and cell motility (Macias-Perez et al., 2008) .
Colorectal cancer
Note
Integrin α1β1 is up-regulated in 65% of colon adenocarcinomas compared to matched margins. Expression is found to be higher in epithelial cells and the surrounding reactive cells (Boudjadi et al., 2013) . Also, α1β1 is present in the early stages of colorectal cancer which could constitute a useful early diagnostic marker.
Hepatocellular carcinoma
Note
In a fibrotic microenvironment similar to that of hepatocellular carcinoma, α1β1 has been reported to be able to enhance cell invasion through the fibrotic matrix (Yang et al., 2003) .
